ARTL
ARTL
NASDAQ · Pharmaceuticals

Artelo Biosciences Inc

$4.12
+0.18 (+4.57%)
As of Sep 21, 6:20 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +281.1% upside
Low Target $11.87
Average Target $15.70
High Target $22.80
Current Price $4.12
Current
$4.12
Target
$15.70
$11.87 $15.70 avg $22.80
Scenario Analysis
Bear Case
$11.87
188.1%
Low target
Base Case
$15.70
+281.1%
Avg target
Bull Case
$22.80
+453.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$179.19
-97.7% from high
52-Week Low
$3.45
+19.4% from low
Target vs 52W High
$15.70
-91.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%